Using Probiotics and Antibodies to Prevent Rotavirus Diarrhea
Author Information
Author(s): Neha Pant, Harold Marcotte, Harald Brüssow, Lennart Svensson, Lennart Hammarström
Primary Institution: Karolinska Institutet
Hypothesis
Can a combination of Lactobacillus rhamnosus GG and antibodies effectively prevent rotavirus diarrhea in a mouse model?
Conclusion
The combination of Lactobacillus rhamnosus GG and specific antibodies significantly reduces the prevalence and severity of rotavirus diarrhea.
Supporting Evidence
- Lactobacillus rhamnosus GG significantly reduced diarrhea prevalence to 41% compared to 93% in untreated mice.
- The combination treatment prevented histopathological changes associated with rotavirus infection.
- Daily administration of antibodies resulted in a 75% decrease in diarrhea prevalence on day 2.
Takeaway
This study found that giving a special type of good bacteria and antibodies together can help stop babies from getting sick with diarrhea caused by rotavirus.
Methodology
Mice were given different doses of Lactobacillus rhamnosus GG and antibodies, then challenged with rotavirus to assess diarrhea prevalence and severity.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Infant mice were used in the study.
Statistical Information
P-Value
0.0005
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website